TABLE 2.
Potential biomarkers discovered by VIP, FC, and adjusted p-values.
| Different metabolites | VIP | FC | P-value |
| NC vs. GDM | |||
| C18:1 | 2.45 | 1.24 | 0.003 |
| 2-Hydroxybutyric acid | 1.91 | 1.62 | 0.001 |
| Pyroglutamic acid | 2.89 | 0.65 | <0.001 |
| Glutamic acid | 1.27 | 1.21 | 0.042 |
| NC vs. HP | |||
| C16:0 | 2.67 | 1.32 | <0.001 |
| C18:0 | 1.27 | 1.24 | 0.011 |
| C18:1 | 2.18 | 1.47 | <0.001 |
| Pyroglutamic acid | 1.82 | 1.44 | 0.001 |
| Glycine | 1.20 | 1.25 | 0.008 |
| γ-Aminobutyric acid | 5.57 | 1.36 | <0.001 |
| Glutamic acid | 1.33 | 1.33 | 0.001 |
| GDM vs. HP | |||
| C18:1 | 1.11 | 1.21 | 0.005 |
| Pyroglutamic acid | 2.84 | 2.21 | <0.001 |
| γ-Aminobutyric acid | 5.84 | 1.38 | <0.001 |
| Creatinine | 1.03 | 1.48 | <0.001 |
P-values in bold indicate that there are significant differences between the NC, GDM, and HP groups.